LifeMatrix Technologies
Z├╝rich
About LifeMatrix Technologies
Active in the field of biomimetic implants, LifeMatrix develops human cell derived, off-the-shelf available tissue engineered implants, which transform into living tissue after implantation and have the capacity to grow and regenerate with the patient. The award winning technology is the result of multiple national and international research grants and is backed by >20 years of research with >100 peer-reviewed publications. Extensive preclinical (animal) studies demonstrated safety and efficacy and allow the technology to be translated in to clinical application.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $173.1K
- Last round: Grant (Nov 2021)
- Website: lifematrixtechnologies.com
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/lifematrix-technologies-162782 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.